Article R5134-162
…trategy for implementing jobs with a future, in particular : 1° The priority industries and sectors of activity for the deployment of jobs with a future, in particular those sectors which have a high…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 1411–1420 of 54664 articles for “Art. Loi 2012-958 of 16 Aug. 2012”
…trategy for implementing jobs with a future, in particular : 1° The priority industries and sectors of activity for the deployment of jobs with a future, in particular those sectors which have a high…
…g and Vocational Guidance is consulted on the regional guidance plan referred to in article R. 5134-162 and, where applicable, on the results of future employment for the previous year. II - The draft…
The fulfilment of the employer's commitments, particularly with regard to training, is examined by the authority issuing the decision to grant the aid at each annual deadline. In the event of non-comp…
…ng on the labelling must be written at least in French. The labelling must guarantee the protection of the person undergoing the research and traceability, enable the product and the trial to be ident…
…ental surgeon, midwife, pharmacist or nurse shall immediately report any adverse reaction suspected of being due to a medicinal product or to a product mentioned in article R. 5121-150 of which he is…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 shall implement a pharmacovigilance system in order to fulfil its pharmacovigilance obligations…
Any company or organisation exploiting a medicinal product or a product mentioned in Article R. 5121-150 is required to: 1° Record all adverse reactions suspected of being due to a medicinal product o…
Any company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 has at its disposal on a permanent basis the services of a person responsible for pharmacovig…
The company or organisation exploiting a medicinal product or a product referred to in Article R. 5121-150 may not communicate information relating to pharmacovigilance to the general public about thi…
…t, refer the matter to the Committee for Medicinal Products for Human Use referred to in Article 56 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or to the coordination…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More